Antiplatelet therapy for the prevention of arterial ischemic events in takayasu arteritis

Circulation Journal

Volumn 74, Issue 6, 2010, Pages 1237-1241

  de Souza, Alexandre W S ^a   Machado, Natália P ^a   Pereira, Vanessa M ^a   Arraes, Anne E D ^a   Reis Neto, Edgard T ^a   Mariz, Henrique A ^a   Sato, Emilia Inoue ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aspirin; Cardiovascular diseases; Ischemia; Takayasu arteritis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CLOPIDOGREL; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PHENPROCOUMON; PREDNISONE; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AORTA ARCH SYNDROME; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIA; MALE; OBESITY; PRIMARY PREVENTION; PROTECTION; RETROSPECTIVE STUDY; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; ADOLESCENT; ARTERY; CARDIOVASCULAR DISEASE; COMORBIDITY; PATHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICOAGULANTS; ARTERIES; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; ISCHEMIA; MALE; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TAKAYASU ARTERITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953521580     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0905     Document Type: Article

References (30)

1. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rotten M, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919-929.
2. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: A review. J Clin Pathol 2002; 55: 481-486.
3. Maksimowicz-McKinnon K, Hoffman GS. Takayasu arteritis: What is the long-term prognosis? Rheum Dis Clin N Am 2007; 33: 777-786.
4. Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet 2000; 356: 1023-1025.
5. Akazawa H, Ikeda U, Yamamoto K, Kuroda T, Shimada K. Hyper-coagulable state in patients with Takayasu's arteritis. Thromb Hae-most 1996; 75: 712-716.
6. Kasuya N, Kishi Y, Isobe M, Yoshida M, Numano F. P-selectin expression, but not GPHb/ffla activation, is enhanced in the inflammatory stage of Takayasu's arteritis. Circ J 2006; 70: 600-604.
7. Numano F, Shimokado K, Kishi Y, Nishiyama K, Türkoglu C, Yajima M, et al. Changes in the plasma levels of thromboxane B2 and cyclic nucleotides in patients with Takayasu disease. Jpn Circ J 1982; 46: 16-20.
8. Watanabe T, Kishi Y, Numano F, Isobe M. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arte-ritis. Thromb Res 2001; 104: 77-83.
9. Ogino H, Matsuda H, Minatoya K, Sasaki K, Tanaka H, a, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 2008; 118: 2738-2747.
10. Tabuchi A, Taniguchi R, Takahashi K, Kondo H, Kawato M, Morimoto T, et al. Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method. Circ J 2008; 72: 420-426.
11. Pamukcu B, Oflaz H, Onur I, Midilli K, Yilmaz G, Yilmaz E, et al. Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease. Circ J 2008; 72: 61-66.
12. Numano F, Maruyama Y, Koyama T, Numano F. Antiaggregative aspirin dosage at the affected vessel wall. Angiology 1986; 37: 695-701.
13. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-1134.
14. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996; 54(Suppl): S155-S163.
15. NCEP Expert Panel: Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl 1): S5-S20.
17. Stassen PM, Derks RP, Kallenberg CG, Stageman CA. Venous thromboembolism in ANCA-associated vasculitis-incidence and risk factors. Rheumatology (Oxford) 2008; 47: 530-534.
18. Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: A systematic retrospective study on 1130 patients. Ann Rheum Dis 2009; 68: 564-567.
19. Ray JG, Mamdani MM, Geerts WH. Giant cell arteritis and cardiovascular disease in older adults. Heart 2005; 91: 324-328.
20. Le Page L, Duhaut P, Seydoux D, Bosshard S, Ecochard R, Abbas F, et al. Incidence of cardiovascular events in giant cell arteritis: Preliminary results of a prospective double cohort study (GRACG). Rev Med Interne 2006; 27: 98-105.
21. Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54: 3306-3309.
22. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M, et al. Lowdose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50: 1332-1337
23. Narváez J, Bernad B, Nolla JM, Valverde J. Statin therapy does not seem to benefit giant cell arteritis. Semin Arthritis Rheum 2007; 36: 322-327.
24. Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 2006; 65: 1202-1207.
25. Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y. Atherosclerotic lesions in Takayasu arteritis. Ann N Y Acad Sci 2000; 902: 65-76.
26. Filer A, Nicholls D, Corston R, Carey P, Bacon P. Takayasu arteritis and atherosclerosis: Illustrating the consequences of endothelial damage. J Rheumatol 2001; 28: 2752-2753.
27. Rose AG, Sinclair-Smith CC. Takayasu's arteritis: A study of 16 autopsy cases. Arch Pathol Lab Med 1980; 104: 231-237.
28. De Souza AW, Ataíde Mariz H, Torres Reis Neto E, Arraes AED, Silva NP, Sato EI. Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients. Clin Rheumatol 2009; 28: 379-383.
29. De Carvalho JF, Bonfá E, Bezerra MC, Pereira RM. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 2009; 28: 801-805.
30. Espinola-Zavaleta N, Soto-López ME, Carréon-Torres E, Gamboa R, Mejía AM, Marquez-Velasco R, et al. Altered flow-mediated vasodilation, low paroxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis. Circ J 2009; 73: 760-766.